How can cognitive behavioral therapy help alleviate symptoms of ADHD patients, as well as other symptoms of comorbid anxiety or depression in these patients? Is cognitive behavioral therapy more effective than other types of group or individual counseling for these patients? Dr. Mary Solanto, associate professor of psychiatry and director of the ADHD Center at the Mount Sinai School of Medicine, describes some of the benefits ADHD patients may receive from this non-pharmacologic approach to treatment. Dr. Vatsal Thakkar hosts.
Cognitive Behavioral Therapy in Adults With ADHD
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
How can cognitive behavioral therapy help alleviate symptoms of ADHD patients, as well as other symptoms of comorbid anxiety or depression in these patients? Is cognitive behavioral therapy more effective than other types of group or individual counseling for these patients? Dr. Mary Solanto, associate professor of psychiatry and director of the ADHD Center at the Mount Sinai School of Medicine, describes some of the benefits ADHD patients may receive from this non-pharmacologic approach to treatment. Dr. Vatsal Thakkar hosts.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
CME/CE
Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring
1.00 credits
<p>Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring</p>
CME/CE Broadcast Replay
Pulmonary Hypertension Management: Practice Trends and Updates
1.00 credits
<p>Pulmonary Hypertension Management: Practice Trends and Updates</p>
MinuteCE®
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
0.75 credits
<p><span data-contrast="auto" style="list-style-type: disc;" xml:lang="EN-US">Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies</span></p>
MinuteCE®
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
0.75 credits
<p><span data-contrast="none" style="list-style-type: disc;" xml:lang="EN-US">The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC</span></p>
NeuroFrontiers
Respiratory Dysfunction in Neuromuscular Disorders: Evaluating Symptoms
<p>Respiratory Dysfunction in Neuromuscular Disorders: Evaluating Symptoms</p>
NeuroFrontiers
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
<p>Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data</p>
Advances in Women's Health
Improving the IUD Experience: Evidence-Based Pain Management Approaches
<p>Improving the IUD Experience: Evidence-Based Pain Management Approaches</p>
Clinician's Roundtable
Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025
<p>Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?